Axsome Therapeutics AXSM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$188.3M-2.8% | -$183.17M+20.2% | -$229.53M+7.0% | -$246.9M+11.3% | -$278.27M+3.1% | ||
| $470K-6.6% | $503K-2.9% | $518K-2.1% | $529K-3.6% | $549K+3.2% | ||
| $93.88M+0.1% | $93.75M+0.8% | $93.01M+1.6% | $91.57M+3.7% | $88.34M+3.7% | ||
| -$71.78M+24.0% | -$94.45M+7.4% | -$102M+15.4% | -$120.63M-2.0% | -$118.32M+7.9% | ||
| $263K-45.2% | $480K+9.3% | $439K-6.8% | $471K-7.6% | $510K+88.9% | ||
| -$263K+45.2% | -$480K-9.3% | -$439K+6.8% | -$471K+7.6% | -$510K-88.9% | ||
| —— | —— | —— | —— | —— | ||
| $75.19M-25.9% | $101.47M+2.2% | $99.32M-8.4% | $108.46M+22.8% | $88.3M+52.7% | ||
| —— | —— | —— | —— | —— | ||
| -$71.98M+24.1% | -$94.87M+7.3% | -$102.38M+15.5% | -$121.1M-1.9% | -$118.83M+7.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Axsome Therapeutics generate?
- Axsome Therapeutics (AXSM) generated -$71.8M in operating cash flow over the trailing twelve months.
- What is Axsome Therapeutics's free cash flow?
- After $263.0K of capital expenditures, Axsome Therapeutics's free cash flow was -$72.0M over the trailing twelve months, up 39.4% year over year.
- Where does Axsome Therapeutics's cash flow data come from?
- Every line is extracted from Axsome Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
